Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Clinical research

Designated pharmacist to review procedures for trials of cancer drugs

All trials carried out by the Experimental Cancer Medicine Centres network will require only a single review by a designated pharmacist who will share results with other sites.

New clinical trial procedures for cancer drugs will be streamlined to prevent duplication and reduce bureaucracy

Source: Age Fotostock Spain, S.L. / Alamy

Trials carried out by the Experimental Cancer Medicine Centres network will use streamlined procedures during their set-up

Changes to clinical trial procedures for new cancer drugs will prevent duplication, reduce bureaucracy and speed up patient access to new products.

Under existing procedures, all sites involved in a clinical trial have to carry out their own technical pharmacy review. The review, which takes place during the set-up of the trial, includes looking at practicalities such as product safety data and how the drugs will be ordered.

But in future, all trials carried out by the Experimental Cancer Medicine Centres (ECMC) network — a joint initiative between Cancer Research UK and the four UK health departments — will require only a single review by a designated pharmacist who will then share the results with the other trial sites.

The change in the system has been coordinated by the Health Research Authority (HRA) — the organisation that streamlines the regulation of UK research — as part of its new clinical trials approval process.

Janet Messer, programme director for the HRA approval programme, said the new procedure was “an important step in the process of implementing HRA approval in a controlled and collaborative way”.

 “We welcome this new initiative, which is the result of many months of hard work and consultation with NHS pharmacists working across the ECMC network and builds on local initiatives already under way,” said Tim Root, honorary secretary of the National Pharmacy Clinical Trials Advisory Group at the Royal Pharmaceutical Society.

“Pharmacists’ continued input will be vital to ensure that this new approach can work on a national scale and we look forward to supporting wider implementation.”

The initiative was also welcomed by Richard Baird, an oncologist involved in a trial looking at potential new treatments for people with lung cancer or breast cancer who go on to develop operable brain metastases. That trial currently involves three different centres but will be rolled out to twelve as it progresses.

“Every aspect of setting up a clinical trial is hugely time consuming and sometimes there is a lot of duplication,” he said. “This is one of those changes which seems obvious and you think why haven’t we been doing this for the last ten years?”

Peter Johnson, Cancer Research UK’s chief clinician, described it as an “important initiative to streamline the regulation of clinical research, so patients can continue to reap the benefits of the world-class research taking place throughout the UK”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066776

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Handbook of Drug Administration via Enteral Feeding Tubes

    Handbook of Drug Administration via Enteral Feeding Tubes

    All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.

    £54.00Buy now
  • Prescribing Medicines for Children

    Prescribing Medicines for Children

    Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.

    £60.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Palliative Care Formulary (PCF6)

    Palliative Care Formulary (PCF6)

    Palliative Care Formulary is a comprehensive combination of independent information about drugs used in palliative care.

    £55.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.